Quotes with Resistance & Support
Market Information
Buy Piramal Healthcare, target of Rs 290: Motilal Oswal
Posted on: February 25th, 2009 and is filed under Brokerage Recommendations.
Motilal Oswal has maintained its buy rating on Piramal Healthcare with a target price of Rs 290 in its February 16, 2009 research report. “Piramal Healthcare’s 3QFY09 performance was below estimates, with topline growth of 13.1% to Rs 8.3 billion v/s estimate of Rs 8.65 billion, EBITDA margin at 18.8% v/s estimate of 20% and PAT decline of 23% to Rs 599 million v/s estimate of Rs 976 million. We estimate that adjusted for NCE hive-off, PAT has de-grown by 39% for 3QFY09. We reiterate Buy with a target price of Rs 290 (12x FY10E EPS), an upside of 58%,” says Motilal Oswal’s research report.
Tags: calls, daytrading, free calls, intraday, tips
Similar Posts:
Latest Query
Samrudhiglobal.com wishing you and your friends and family Advance xmas and Happy New year...view more »
- by Sam
- by Sam
Status: Awaiting reply
Market Stats
Search Our Archives
Research Desk
- Stocks Trading above their 50 day moving average - DMA In Stock Research
- Download free Ebooks based on Technical Analysis In Personal Training
- TOP 100 Stocks with the Highest P/E as on July 14th, 2013 In Stock Research
- TOP 100 Stocks with the Lowest P/E as on July 14th, 2013 In Stock Research
- Charting Pathsala - Your guide to Techincals In Technical Analysis
